GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR

Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.

Never miss a new study

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear

Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 2 Terminated 1

Radioactive drug tested to stop Cancer's return after liver surgery

Disease control Terminated

This study tested whether giving Lutathera, a targeted radioactive drug, after surgery to remove neuroendocrine tumor spread in the liver could prevent the cancer from coming back. It compared this treatment against standard monitoring and supportive care in patients whose primar…

Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR

Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR

Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear

Radioactive drug tested to stop Cancer's return after liver surgery